encyclopedia jump navigation search hepatitis change cell death body disease gastroenterology symptom skin appetite pain complication liver failure cancer duration term cause  alcohol toxin  prevention vaccination treatment transplant frequency case year 
hepatitis inflammation liver tissue people symptom discoloration skin white eye appetite vomit tiredness pain term month progress result failure time form scare cancer 
cause hepatitis  alcohol use medication toxin infection  disease  type food water  mother baby pregnancy childbirth  blood needle share drug user  people 
hepatitis immunization case treatment  activity diet weight loss medication system liver transplant option 
hepatitis people united  nash result death year liver scare cancer word  
mean liver  
mean inflammation content 
sign symptom hepatitis cause mechanism diagnosis alcoholic screen prevention vaccine change treatment recommendation epidemiology history thought state school experiment  antigen society culture burden case research direction population  pregnancy reference link 
sign symptom eye 
hepatitis spectrum presentation range lack symptom liver failure form infection sign dysfunction inflammation damage organ 
hepatitis phase 
prodromal phase symptom infection 
fatigue nausea appetite pain headache fever present case hepatitis phase people symptom urine  stool skin white eye prodrome week prodromal time liver discomfort spleen weight loss recovery resolution elevation lab value resolve month  
case hepatitis  
hepatitis  variation symptom cause case sign reaction fever inflammation membrane organ  type blood cell suppression bone marrow activity 
hepatitis cell death complication case    addition  instance  rate  sign people  coagulation study encephalopathy confusion disorientation sleepiness mortality result sepsis failure kidney 
case hepatitis period 
hepatitis month course liver laboratory study screen purpose symptom inflammation patient fatigue nausea appetite pain disease process sign function acne hair growth lack period  damage scare time cirrhosis condition ability result jaundice weight loss   fluid collection edema leg swell complication encephalopathy  syndrome cancer cause 
cause hepatitis category ischemic  
agent  bacteria parasite 
drug alcohol liver disease cause injury inflammation 
cause hepatitis predisposition population 
hepatitis article 
hepatitis type  route country illness 
hepatitis    blood mucous membrane body fluid semen secretion particle saliva  
share utensil  transmission fluid sore cut 
hepatitis    virus adult infection progress state cirrhosis liver cancer infant  
hepatitis  case  lead infection second cause cirrhosis blood transfusion factor spread virus screen product risk  
liver response symptom hepatitis serum infection protozoan  plasmodium inflammation cause abscess 
worm echinococcus dog tapeworm liver form characteristic hydatid cyst fluke hepatica  bile duct cause hepatitis fibrosis 
infection liver result abscess hepatitis disease bacteria  coly  time   salmonella    article 
alcohol consumption cause hepatitis cirrhosis spectrum liver disease 
range order severity reversibility steatosis hepatitis cirrhosis liver cancer exposure alcohol  risk factor development quantity duration intake excess gram day men  alcoholic beer ounce wine  symptom failure 
agent medication toxin supplement hepatitis spectrum liver injury failure variety mechanism cell damage disruption metabolism change drug  exhibit  cause reaction individual variation latency period exposure development illness 
type drug liver injury analgesic      steroid contraceptive  therapy treatment  cause toxicity failure united   
remedy supplement cause hepatitis  drug liver injury network case  united  food administration institute health  consumer prescription  compound 
exposure  ingestion inhalation skin absorption 
toxin carbon tetrachloride mushroom  liver disease article 
hepatitis spectrum liver disease severity reversibility  nash cirrhosis cancer 
liver disease people history alcohol use syndrome obesity insulin resistance   time  hepatitis cell death inflammation fibrosis factor progression  nash age  female gender  hypertension alt ast level ratio platelet count  score 
stage  patient quadrant pain diagnosis basis liver function test disease symptom hepatitis image biopsy inflammation fibrosis characteristic nash cirrhosis cause united  article 
hepatitis disease response liver cell predisposition  antigen   diagnosis patient antibody muscle  autoantibody kidney sla drug   transplant  virus measle 
hepatitis spectrum liver failure patient  time diagnosis basis function test case sign symptom  disease  sex age fatigue anorexia acne arthritis pleurisy colitis rash risk cirrhosis cancer year 
people  hepatitis disease liver cirrhosis cholangitis 
disease scare fibrosis cirrhosis liver 
cause hepatitis deficiency  disease mutation gene result accumulation protein liver cell storage mineral amount iron body site cirrhosis excess copper brain dementia 
liver deficiency  disease hepatitis period childhood adulthood onset age article 
hepatitis shock liver result blood flow heart failure insufficiency condition sepsis 
blood test person hepatitis level  enzyme ast alt 
condition cause 
hepatitis liver damage article 
hepatitis neonate variety cause adult infection   rubella  syphilis abnormality cyst liver injury disease glycogen storage disorder case biopsy multinucleate cell tissue  drug toxicity mechanism 
mechanism cause hepatitis 
insult liver injury activation response fibrosis cirrhosis hepatitis stage disease 
pathway  hepatitis case    cell death infection liver arm system response damage strength type ability virus defense clearance disease persistence presence result wave inflammation injury wound heal time lead scare fibrosis carcinoma individual risk killer driver  environment recruitment  function 
hepatitis liver disease culmination cascade event injury 
case  hepatitis cascade change metabolism obesity insulin resistance  excess alcohol use culprit event progression accumulation acid breakdown product liver cell process  ability homeostasis effect molecule set stress response time deposition system receptor production   cause injury death transition fibrosis cirrhosis carcinoma evidence  necrosis inflammation zone variable degree body diagnosis  alt    disease   deficiency ischemic elevation ast 
diagnosis hepatitis basis patient sign symptom history substance use blood test image liver biopsy general cause picture case gold standard analysis extent pattern inflammation fibrosis risk bleed injury cirrhosis 
blood test liver enzyme autoantibody acid hepatitis virus chemistry count characteristic pattern abnormality cause stage ast alt case patient symptom degree elevation level predominance 
alt elevation ratio ast diagnosis 
   change liver tissue  surface cirrhosis level detail visualization structure vessel tumor steatosis image test inflammation hepatitis fibrosis biopsy article 
hepatitis blood test level antigen surface core antibody    infection week  recovery  body year patient virus vaccination 
case hepatitis  blood test virus antigen component particle antibody combination positivity information stage infection degree replication infectivity 
factor  hepatitis ash nonalcoholic nash history alcohol use abuse patient diagnosis 
alcohol diagnosis hepatitis obesity  syndrome 
case alcoholic hepatitis pattern liver enzyme abnormality   ratio  
note liver biopsy find patient ash nash presence infiltration  necrosis  form degeneration  body fibrosis vein  hepatitis 
purpose screen hepatitis people disease treatment progression transmission 
hepatitis cause illness liver disease 
role screen status people risk virus liver disease hepatitis infection failure group vaccine 
risk need screen 
people habit wash hand  diaper access water contact hepatitis drug user liver disease area 
presence  hepatitis  blood infection virus vaccination  
 routine hepatitis  screen population people 
country prevalence hepatitis 
population state parent country prevalence hepatitis 
population  drug user men sex contact people hepatitis  therapy liver enzyme cause blood organ tissue donor 
screen blood test hepatitis  surface antigen  
 second test blood sample antibody hepatitis core antigen infection people  vaccine  
   screen people risk hepatitis  infection population 
drug user past men sex  recipient tattoo set blood product organ united  adult state  mother worker  injury donor 
people group exposure screen research interval  men sex  risk 
screen blood test hepatitis  virus antibody 
hepatitis  virus antibody test  disease prevention vaccine immunization schedule united  age year  article 
 hepatitis vaccine  age risk disease 
 month age vaccination shot muscle dose adult type vaccine 
vaccine hepatitis dose month manufacturer  article 
 routine vaccination  age hepatitis vaccine risk 
routine vaccination hepatitis  dose shot muscle hospital 
dose child month 
baby mother hepatitis  surface antigen positivity dose addition vaccine globulin hour birth 
 infection year life 
combination formulation hepatitis  vaccine 
vaccine united  hepatitis   change 
hepatitis route mainstay prevention vaccination hygiene access water handle sewage   
hepatitis   blood fluid prevention screen transfusion use injection drug needle sharp practice  set sex  
hepatitis  virus person prevention effort spread  
people hepatitis infection risk superinfection  virus strategy 
hepatitis  route blood mother fetus 
mainstay hepatitis  prevention hygiene water practice 
alcohol consumption hepatitis cirrhosis recommendation 
drink day 
drink week men 
drink day 
drink week 
united  immunization decrease hospital admission expense hepatitis 
united  case hepatitis  group decrease  adolescent implementation guideline  
hepatitis  infection year data decline needle exchange  
people hepatitis symptom number disease estimate program  death cirrhosis success incidence treatment 
treatment hepatitis form severity disease cause 
hepatitis article 
hepatitis state hospitalization treatment measure hydration nutrition 
people hepatitis virus liver failure disease  mortality risk factor age case therapy transplant article 
patient effect treatment age  condition illness 
patient warrant hospitalization sign  encephalopathy laboratory prothrombin time serum albumin bilirubin 
case patient therapy hepatitis analogue 
dearth trial data drug treat resistance expert treatment case 
hepatitis management replication progression disease drug treatment date united  
 alpha therapy hepatitis  side effect removal treatment indication polyethylene glycol nucleoside analogue peg  week injection resistance antiviral monitor cost  year united  medication duration patient minimum level activity cirrhosis  world area agent course month consolidation 
response therapy patient consolidation year reactivation treatment  resistance duration antiviral  part regimen nucleotide analogue  hepatitis choice    drug infection 
treatment peg  subject patient physician preference initiation recommendation association study liver disease level status alt case family history  biopsy cirrhosis     evaluation transplantation term   hepatitis  article 
contrast hepatitis  progression  goal treatment prevention carcinoma way risk  response  load week completion cure drug act  peg   combination basis therapy duration genotype agent area country target protein replication class 
protease inhibitor     
drug combination  patient genotype  united  world act regimen therapy   week fibrosis cirrhosis disease need treatment cost factor access nation 
association study liver disease society  treatment patient hepatitis  infection condition life expectancy  article 
hepatitis  treatment 
alpha activity basis hepatitis  article 
hepatitis treatment  rest nutrition hydration hospitalization case  
treatment hepatitis alcoholism alcohol reversal liver disease life patient stage benefit prevention injury addition referral psychotherapy program evaluation sign symptom  encephalopathy infection 
hepatitis prognosis treatment patient month evidence life mortality option   inhibitor        data infection kidney failure pancreatitis case basis lieu benefit placebo drug risk term 
evidence milk thistle extract survival liver disease test serum bilirubin  side effect recommendation study 
people hepatitis bed rest activity diet nausea food day bulk intake part phase disease feed patient vomit 
people hepatitis drug liver treatment option harm development 
precaution isolation case incontinence hepatitis  bleed   
patient hepatitis infection complication 
hepatitis infection course recovery  patient factor outcome condition present symptom  encephalopathy mortality rate total case population    
contrast hepatitis risk cirrhosis patient  
complication hepatitis pancreatitis neuropathy 
course case hepatitis complication 
hepatitis 
case hepatitis   mortality rate rise patient recovery 
liver transplantation patient failure 
hepatitis  infection case  phenomenon 
hepatitis infection progress form age patient increase rate progression case infant risk adult survival range cirrhosis 
patient hepatitis  time  infection people  liver disease progression 
hepatitis  cirrhosis estimate prevalence year infection cause mortality end stage liver disease carcinoma term complication death 
rate mortality increase progression liver disease 
series patient cirrhosis  survival rate drop 
epidemiology hepatitis 
hepatitis world outbreak  contamination water food source infection  age infant illness contrast adult rate resource country sanitation population region year disease availability childhood vaccine united  incidence risk men sex exposure primate individual clote disorder factor history liver drug user article  
hepatitis  cause world carrier virus united  patient infection exposure lifetime risk drug user individual behavior  worker history transfusion organ transplant dialysis  process death region  east  adult rate nation population transmission birth contact infant  article 
hepatitis  cause liver cirrhosis carcinoma reason transplantation complication people world disease population region   south  prevalence  rate infection contamination schistosomiasis treatment  united  adult  group carrier status mode transmission virus exposure blood product transfusion drug injection history risk factor individual behavior infant mother  worker  article 
hepatitis  virus context  contact needle region united  northern  population risk drug user individual transfusion   article  
hepatitis  outbreak  contamination water source death people virus adult  infection trimester mortality rate individual system organ transplant recipient united  world    east genotype evidence animal reservoir 
hepatitis form mortality people men  risk complication secondary body fat difference alcohol metabolism factor age binge pattern status obesity  population presence virus disease progression cirrhosis carcinoma likelihood individual alcoholic proportion progress 
 hepatitis nash reason liver transplantation united  year supplant disease  population prevalence world patient cirrhosis progress carcinoma  cause history thought 
account syndrome hepatitis 
clay tablet handbook  observation jaundice 
 liver home soul find jaundice attack devil   documentation epidemic course cohort patient week 
bile liver phlegm blood  eruption patient talk nonsense bark dog 
condition war jaundice role cause mortality troop world estimate soldier hepatitis 
soldier vaccine disease fever serum  hepatitis researcher    agent virus case jaundice month vaccination  patient 
seed virus strain case jaundice vaccination state school experiment 
new york university researcher   research experiment  state school facility hepatitis infection student body 
student gamma type antibody 
protection infection antibody hepatitis virus student 
student   
research controversy people ethics target population 
henry   article new  journal medicine parent risk consent research benefit expense  family project admission school support resource community term understand hepatitis virus  example debate ethics  antigen 
leap research  
researcher  research hepatitis lipoprotein genetics 
globe collect blood sample interplay disease environment genetics goal intervention individual interaction patient hemophilia transfusion protein aborigine  antigen focus research 
prevalence protein blood patient country association antigen disease leukemia syndrome conclusion  hepatitis 
  hepatitis    hospital  particle association surface virus  antigen  
antigen hepatitis  vaccine plasma   prize medicine 
citation society culture burden 
hepatitis account portion  expenditure nation rise country infection event cost united  case average work day adult report hospitalization  effectiveness study vaccination combination   risk group people area worker 
hepatitis  account percentage health care spend region  south  expenditure cost majority sum disease symptom complication infection united  hospitalization year number introduction drug therapy vaccination campaign 
people hepatitis  user health care system person united  cost number cirrhosis time effect study canada expenditure virus peak  year case 
outbreak hepatitis virus united  history people food restaurant     result attention health official emergency medicine physician increase case county investigation  source use onion 
restaurant onion stock farm  time use water crop irrigation rinse ice handle vegetable individual outbreak hepatitis state magnitude  bucket plant number vector infection source people globulin contact research direction  
paper mouse model hepatitis infection protein clearance virus implication disease 
hepatitis  
march group china article development vaccine hepatitis  united  government process recruit participant phase trial drug population   
person  burden  study likelihood hepatitis  virus time individual prevalence  people drug use risk factor infection  population men sex   antibody pregnancy  
transmission contributor  case year  mother neonate country exposure blood secretion birth risk progression infection adult virus subject   
risk transmission  screen   visit vaccine evidence association study liver disease therapy load body trimester neonate review pregnancy registry  anomaly  reason potency resistance  drug  effect 
state evidence mode delivery  transmission mother  
 neonate mother  hepatitis globulin vaccine hour birth infant   
estimate rate transmission range review  risk  study virus mother blood 
evidence mode delivery  effect transmission 
   guideline nipple risk transmission hepatitis  
 contract risk hepatitis mortality rate trimester review  study people   failure 
